Skip Nav Destination
Article navigation
Meeting Abstracts|
September 2000
Room A, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Single Dose Tolerability and Pharmacokinetics of Parecoxib Sodium, a COX-2 Specific Inhibitor, Following Intravenous Administration : A-945
GD Searle & Co., Skokie, IL, United States.
Anesthesiology September 2000, Vol. 93, A–945.
Citation
Aziz Karim, Aziz Laurent, Jiang Qian, Michael Kuss, Richard Hubbard; Room A, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Single Dose Tolerability and Pharmacokinetics of Parecoxib Sodium, a COX-2 Specific Inhibitor, Following Intravenous Administration : A-945. Anesthesiology 2000; 93:A–945 doi: https://doi.org/10.1097/00000542-200009001-00945
Download citation file:
Citing articles via
Most Viewed
Related Articles
Effects of Parecoxib, a Parenteral COX-2-specific Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Propofol
Anesthesiology (January 2002)
Parecoxib Sodium, a Parenteral Cyclooxygenase 2 Selective Inhibitor, Improves Morphine Analgesia and Is Opioid-sparing following Total Hip Arthroplasty
Anesthesiology (April 2003)
Efficacy and Safety of Intravenous Parecoxib Sodium in Relieving Acute Postoperative Pain following Gynecologic Laparotomy Surgery
Anesthesiology (August 2002)
Effect of Parecoxib, A Novel Intravenous Cyclooxygenase Type-2 Inhibitor, on the Postoperative Opioid Requirement and Quality of Pain Control
Anesthesiology (June 2002)
Safety and Efficacy of the Cyclooxygenase-2 Inhibitors Parecoxib and Valdecoxib after Noncardiac Surgery
Anesthesiology (March 2006)